Delivery Order SPE2DB22D2006-SPE2DB25FW2TC
- Not listed
- The Defense Logistics Agency awarded a $4,126.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 22, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Candesartan Cilexetil is an angiotensin II receptor blocker commonly prescribed...
- The Defense Logistics Agency awarded a $1,506.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this contract represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in a quantity of 90 units, with a contract ceiling value of $26,852.27. This delivery order represents a competitive, non-set-aside award issued under a firm fixed price structure with an ultimate completion date of July 22, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.69 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units) with a firm fixed price structure. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation and represents a competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- This is a $31,487.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,824,771 units of Candesartan Cilexetil 16 mg tablets. The contract has a completion date of January 3, 2025 and was awarded on January 2, 2025. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) that Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,787.82 firm fixed-price delivery order is for the supply of 4,566,960 units of Candesartan Cilexetil 16 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.23 firm fixed-price contract is for the supply of 90-count bottles of 16 mg Candesartan Cilexetil tablets, a cardiovascular medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,888.05 contract is for the supply of Candesartan Cilexetil 32 mg tablets, with a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $4,326.46 and runs through July 25, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, will supply this prescription medication to support military treatment facilities and other...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2TCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $13,581.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. Candesartan cilexetil is an angiotensin II receptor antagonist used in the treatment of hypertension and heart failure, representing a critical pharmaceutical supply requirement for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to deliver a broad range of generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's role as a primary pharmaceutical distributor through this vehicle demonstrates its critical importance to federal medical procurement operations across multiple therapeutic domains and global locations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 7/23/25 |